Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory, with Excess of Blasts

Explore clinical trials studying Anemia, Refractory, with Excess of Blasts. Study availability and eligibility vary by location and protocol.

249 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory, with Excess of Blasts trial results

Completed

Decitabine in Treating Patients With Myelodysplastic Syndrome

NCT00003361

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

NCT00003619

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +36 more
Locations
  • Medical College of Pennsylvania Hospital Philadelphia, Pennsylvania, United States
  • Medical College of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

NCT00022048

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions